Small nuclear ribonucleoprotein polypeptide N quantitative methylation analysis in infants with central hypotonia

Abstract Central hypotonic is one of the most difficult issues in neurology, ruling out neurogenetic syndromic causes is critical, Prader-Willi syndrome (PWS) it is the most frequent genetic syndrome, it is caused by the loss of expression of the paternal allele in a group of imprinted genes within 15q11-q13, and is characterized by severe prenatal and postnatal hypotonia. SNURF-SNRPN gene methylation detects 99% of the cases but fluorescent in situ hybridization (FISH) analysis is necessary to confirm chromosome microdeletions. The advantage of SNRP-quantitative strategy of methylated alleles is that it makes it possible to make the diagnosis and identify deletions and mosaicism in one reaction. In infants clinical diagnosis is difficult. It has been proposed that around 40% of hypotonic patients have PWS but an accurate percentage has not been established. Twenty-four central hypotonic infants were studied by this molecular strategy, showing 41.5% with the disease. This molecular approach also permitted calculation of gene dosage and detection of those cases with microdeletion.

[1]  M. Tauber,et al.  Recommendations for the diagnosis and management of Prader-Willi syndrome. , 2008, The Journal of clinical endocrinology and metabolism.

[2]  J. Bodensteiner,et al.  The evaluation of the hypotonic infant. , 2008, Seminars in pediatric neurology.

[3]  K. Õunap,et al.  The neonatal phenotype of Prader–Willi syndrome , 2006, American journal of medical genetics. Part A.

[4]  A. Holland,et al.  Prevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: a population-based study. , 2002, Developmental medicine and child neurology.

[5]  K. Macdermot,et al.  Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females , 2001, Journal of medical genetics.

[6]  M. Shevell,et al.  Diagnostic profile of neonatal hypotonia: an 11-year study. , 2001, Pediatric neurology.

[7]  C. Koiffmann,et al.  [Hypotonic infants and the Prader-Willi Syndrome] , 2000, Jornal de pediatria.

[8]  A. Mensire,et al.  [Neonatal presentation of Prader-Willi syndrome]. , 2000, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[9]  B. Horsthemke,et al.  A previously unrecognised phenotype characterised by obesity, muscular hypotonia, and ability to speak in patients with Angelman syndrome caused by an imprinting defect , 1999, European Journal of Human Genetics.

[10]  M. Shevell,et al.  The neonatal presentation of Prader-Willi syndrome revisited. , 1999, The Journal of pediatrics.

[11]  Stefan Böhringer,et al.  A novel real-time PCR assay for quantitative analysis of methylated alleles (QAMA): analysis of the retinoblastoma locus. , 2004, Nucleic acids research.